Skip to main content
Signal8

iRhythm Holdings, Inc. (IRTC)

iRhythm Technologies, Inc. is a digital healthcare enterprise dedicated to offering portable electrocardiogram (ECG) monitoring solutions to individuals in the United States who face the risk of cardiac arrhythmias. Its primary offering, the Zio service, provides a comprehensive ambulatory cardiac monitoring system. This system ingeniously combines a wireless, patch-based, and wearable biosensor—specifically embodied in products like the Zio XT and AT monitors—with a sophisticated cloud-based data analysis platform. These single-use biosensors precisely record a patient's heartbeats and ECG data, thereby enabling medical professionals to effectively oversee patient heart health and accurately diagnose arrhythmias. Furthermore, iRhythm maintains a strategic development partnership with Verily Life Sciences LLC, focused on pioneering future atrial fibrillation screening, detection, and monitoring innovations. Founded in 2006, the company maintains its corporate headquarters in San Francisco, California.

Sector: Surgical & Medical Instruments & Apparatus

Industry: Medical - Devices

iRhythm Technologies, Inc. logo

iRhythm Technologies, Inc.

NASDAQ:IRTCHealthcare
-3.47%$123.37
AH$123.37+0.00%vs close
Mkt Cap$4.07B
Float32.56M
O/S32.96M
Vol
$ Vol
RVOL
Inst Own-
SI9.5%
Earnings
Dilution
Phase Distribution
5 lead-sponsored trials·0 active·4 completed
Not applicable5
(3 more as collaborator)
Status Overview
Not yet recruiting1
Completed4

Trials need funding. See this company's dilution risk and cash position.

Clinical Trials
Sponsor role
Status
  • Observational
    Completed

    True Continuous ECG Monitoring (TCEM Study)

    -

    Cardiac Arrhythmia

    Enrollment
    150
    Start
    Apr 2012
    Primary Completion
    Nov 2012
    Completion
    Dec 2012
    NCT01559246
  • Observational
    Completed

    Extended ECG Monitoring in HCM Patients

    Zio XT

    Hypertrophic Cardiomyopathy, Nonsustained Ventricular Tachycardia +3

    Enrollment
    250
    Start
    Jan 2020
    Primary Completion
    Apr 2022
    Completion
    Apr 2022
    NCT04056715
  • Not applicable
    Completed

    Pediatric Adhesion and New Dermal Approach Study

    Zio monitor

    Syncope, Pediatric +4

    Enrollment
    36
    Start
    Aug 2025
    Primary Completion
    Sep 2025
    Completion
    Jan 2026
    NCT07118124
  • Not applicable
    Completed

    Validation Study: Extended Wear Performance of the Zio Monitor - SHASTA II

    Zio Monitor

    Cardiac Arrhythmia

    Enrollment
    150
    Start
    Jan 2025
    Primary Completion
    Jul 2025
    Completion
    Nov 2025
    NCT07205367
  • Not applicable
    Not yet recruiting

    Head-to-Head (H2H) Comparison of Ambulatory Cardiac ECG Monitors in Japan

    Application of ambulatory cardiac monitor

    Atrial Fibrillation (AF), Atrial Flutter +12

    Enrollment
    130
    Start
    Sep 2026est.
    Primary Completion
    Mar 2027est.
    Completion
    Dec 2027est.
    NCT07870837